GYRE THERAPEUTICS, INC. (GYRE) Balance Sheet
As of 2026-06-30 (10-Q), GYRE THERAPEUTICS, INC. (GYRE) reported total assets of $199.3M, total liabilities of $34.3M and shareholders' equity of $107.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $43.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GYREGYRE THERAPEUTICS, INC.Follow GYRE — free
—
Price chart with a free account
- Market cap
- 652.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 18 Nov, in 25 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 107.3 | 3.4 | 2.8 | 1.5 | 29.1 | 10.3 | 14.5 | 31.2 | 15.4 | 30.4 | 44.3 | 25.2 | 33.5 | 11.8 | 49.2 | 43.3 | |
| Short-term investments | 87.7 | 42.7 | 37.8 | 51.0 | 3.4 | 6.8 | 18.0 | 88.9 | 61.5 | 49.0 | 2.5 | 0.0 | — | 14.9 | 15.4 | 14.1 | |
| Receivables | — | 1.4 | 0.3 | 0.1 | — | — | — | — | 15.0 | 3.3 | 1.8 | 5.0 | 15.2 | 19.6 | 31.1 | 27.8 | |
| Inventory | — | — | — | — | — | — | — | — | — | — | — | 1.4 | 1.4 | 2.6 | 2.9 | 2.9 | |
| Current assets | 198.2 | 127.7 | 93.6 | 2.1 | 68.7 | 37.5 | 39.1 | 124.0 | 96.1 | 89.5 | 51.5 | 49.7 | 57.2 | 64.8 | 149.4 | 122.1 | |
| Total assets | 258.1 | 189.6 | 145.9 | 3.0 | 69.5 | 38.1 | 39.5 | 124.9 | 98.6 | 94.8 | 55.7 | 84.8 | 116.5 | 125.4 | 219.8 | 199.3 | |
| Current liabilities | 78.6 | 11.3 | 11.0 | 2.3 | 37.8 | 22.0 | 8.7 | 4.8 | 28.9 | 17.8 | 14.2 | 12.2 | 20.0 | 19.5 | 23.8 | 28.7 | |
| Long-term debt | 2.0 | 1.1 | 0.3 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | |
| Short-term debt | 1.2 | 0.9 | 0.9 | — | 33.7 | 19.4 | 5.1 | 0.0 | — | — | — | — | — | — | — | — | |
| Total liabilities | 83.8 | 13.7 | 11.3 | 3.5 | 38.1 | 22.0 | 8.7 | 5.0 | 30.2 | 18.8 | 14.6 | 12.5 | 38.1 | 27.0 | 31.4 | 34.3 | |
| Shareholders' equity | 174.3 | -93.3 | -103.0 | -109.4 | 31.4 | 16.1 | 30.8 | 119.9 | 68.3 | 76.1 | 41.1 | 42.5 | -15.8 | 63.3 | 62.5 | 107.9 |
USD millions · SEC XBRL
GYRE THERAPEUTICS, INC. — questions
- How much cash does GYRE THERAPEUTICS, INC. have?
- $43.3M in cash and cash equivalents as of 2026-06-30.
- What are GYRE THERAPEUTICS, INC.'s total assets?
- $199.3M as of 2026-06-30.
- What is GYRE THERAPEUTICS, INC.'s shareholders' equity?
- $107.9M as of 2026-06-30.
Every figure on this page comes from GYRE THERAPEUTICS, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.